As of March 23, 2026, the three largest insider holders of BHVN are John W Childs (Director, 5.69Mn shares), John W Childs (Director, 5.65Mn shares), Vlad Coric (Chief Executive Officer, 1.80Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John W Childs | 5,691,251 | 0 | 26 Oct, 2022 | |
| John W Childs | 0 | 5,653,904 | 17 Nov, 2025 | |
| Vlad Coric | Chief Executive Officer | 1,803,968 | 0 | 07 Jan, 2026 |
| Vlad Coric | Chief Executive Officer | 0 | 740,546 | 17 Nov, 2025 |
| Matthew Buten | Chief Financial Officer | 195,652 | 0 | 07 Jan, 2026 |
| Kimberly Gentile | Svp, Clinical Operations | 99,557 | 0 | 07 Jan, 2026 |
| George C. Clark | Vp, Chief Accounting Officer | 66,978 | 0 | 07 Jan, 2026 |
| Bruce Car | Chief Scientific Officer | 0 | 30,000 | 20 Jun, 2024 |
| Julia P Gregory | 25,665 | 0 | 26 Oct, 2022 | |
| Kishan Mehta | 5,320 | 17,342 | 19 Mar, 2026 | |
| George C. Clark | Vp, Chief Accounting Officer | 0 | 20,000 | 18 Nov, 2025 |
| Michael Thomas Heffernan | 15,178 | 0 | 12 Oct, 2022 | |
| Robert J Hugin | 12,959 | 0 | 12 Oct, 2022 | |
| Bruce Car | Chief Scientific Officer | 7,715 | 0 | 07 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Kishan Mehta | Common Shares | D | 17,342 | $0.00 | 5,320 | D | G |
| 17 Mar, 2026 | Kishan Mehta | Common Shares | A | 17,342 | $0.00 | 17,342 | I | G |
| 27 Feb, 2026 | Bruce Car | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | Vlad Coric | Stock Options (Right to buy) | A | 550,000 | $0.00 | 550,000 | D | A |
| 27 Feb, 2026 | Kimberly Gentile | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | George C. Clark | Stock Options (Right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 27 Feb, 2026 | Matthew Buten | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 05 Jan, 2026 | Bruce Car | Common Shares | A | 4,750 | $0.00 | 10,096 | D | M |
| 05 Jan, 2026 | Vlad Coric | Common Shares | A | 14,250 | $0.00 | 1,811,398 | D | M |
| 05 Jan, 2026 | Matthew Buten | Common Shares | A | 4,250 | $0.00 | 198,246 | D | M |
| 05 Jan, 2026 | George C. Clark | Common Shares | A | 2,500 | $0.00 | 68,095 | D | M |
| 05 Jan, 2026 | Kimberly Gentile | Common Shares | A | 3,750 | $0.00 | 101,513 | D | M |
| 05 Jan, 2026 | George C. Clark | Common Shares | D | 1,117 | $9.93 | 66,978 | D | F |
| 05 Jan, 2026 | Kimberly Gentile | Common Shares | D | 1,956 | $9.93 | 99,557 | D | F |
| 05 Jan, 2026 | Bruce Car | Common Shares | D | 2,381 | $9.93 | 7,715 | D | F |
| 05 Jan, 2026 | Vlad Coric | Common Shares | D | 7,430 | $9.93 | 1,803,968 | D | F |
| 05 Jan, 2026 | Matthew Buten | Common Shares | D | 2,594 | $9.93 | 195,652 | D | F |
| 05 Jan, 2026 | Matthew Buten | Restricted Share Unit Award | D | 4,250 | $0.00 | 8,500 | D | M |
| 05 Jan, 2026 | Kimberly Gentile | Restricted Share Unit Award | D | 3,750 | $0.00 | 7,500 | D | M |
| 05 Jan, 2026 | Bruce Car | Restricted Share Unit Award | D | 4,750 | $0.00 | 9,500 | D | M |